Gut Liver.  2014 Jan;8(1):94-101.

Differential Expression of E-Cadherin, beta-Catenin, and S100A4 in Intestinal Type and Nonintestinal Type Ampulla of Vater Cancers

Affiliations
  • 1Department of Pathology, Medical Research Institute, Chungbuk National University College of Medicine, Cheongju, Korea.
  • 2Department of Internal Medicine, Medical Research Institute, Chungbuk National University College of Medicine, Cheongju, Korea. smpark@chungbuk.ac.kr
  • 3Department of Surgery, Medical Research Institute, Chungbuk National University College of Medicine, Cheongju, Korea.
  • 4Department of Pathology, Research Center, Aerospace Medical Center, Cheongju, Korea.
  • 5Department of Internal Medicine, Soonchunhyang University Cheonan Hospital, Soonchunhyang University College of Medicine, Cheonan, Korea.
  • 6Department of Internal Medicine, Dankook University College of Medicine, Cheonan, Korea.
  • 7Department of Internal Medicine, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Korea.
  • 8Department of Internal Medicine, Konyang University College of Medicine, Daejeon, Korea.

Abstract

BACKGROUND/AIMS
Epithelial-mesenchymal transition (EMT)-related proteins may exhibit differential expression in intestinal type or pancreatobiliary type ampulla of Vater carcinomas (AVCs). We evaluated the expression of E-cadherin, beta-catenin, and S100A4 in intestinal and nonintestinal type AVCs and analyzed their relationships with clinicopathological variables and survival.
METHODS
A clinicopathological review of 105 patients with AVCs and immunohistochemical staining for E-cadherin, beta-catenin, and S100A4 were performed. The association between clinicopathological parameters, histological type, and expression of EMT proteins and their effects on survival were analyzed.
RESULTS
Sixty-five intestinal type, 35 pancreatobiliary type, and five other types of AVCs were identified. The severity of EMT changes differed between the AVC types; membranous loss of E-cadherin and beta-catenin was observed in nonintestinal type tumors, whereas aberrant nonmembranous beta-catenin expression was observed in intestinal type tumors. EMT-related changes were more pronounced in the invasive tumor margin than in the tumor center, and these EMT-related changes were related to tumor aggressiveness. Among the clinicopathological parameters, a desmoplastic reaction was related to overall survival, and the reaction was more severe in nonintestinal type than in intestinal type AVCs.
CONCLUSIONS
Dysregulation of E-cadherin, beta-cadherin, and S100A4 expression may play a role in the carcinogenesis and tumor progression of AVCs.

Keyword

Ampullary adenocarcinoma; Intestinal type; Pancreatobiliary type; Epithelial-mesenchymal transition

MeSH Terms

Aged
Aged, 80 and over
Ampulla of Vater/*metabolism
Cadherins/metabolism
Common Bile Duct Neoplasms/classification/*metabolism
Disease-Free Survival
Female
Humans
Male
Middle Aged
Prognosis
Retrospective Studies
S100 Proteins/metabolism
Tumor Markers, Biological/*metabolism
beta Catenin/metabolism
Cadherins
S100 Proteins
Tumor Markers, Biological
beta Catenin
Full Text Links
  • GNL
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr